Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Blood|January 9, 2008
APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cellsElodie Belnoue, Maria Pihlgren, Tracy L McGaha, et al.
Oncoimmunology|February 21, 2022
Dissecting the mechanism of cytokine release induced by T-cell engagers highlights the contribution of neutrophilsGabrielle Leclercq, Llucia Alberti Servera, Sabrina Danilin, et al.
Frontiers in Immunology|September 8, 2022
Multi-omics analysis of naïve B cells of patients harboring the C104R mutation in TACINeftali Ramirez, Sara Posadas-Cantera, Niko Langer, et al.
Biochemistry|February 16, 2006
Formation of virus-like clusters is an intrinsic property of the tumor necrosis factor family member BAFF (B cell activating factor)Teresa G Cachero, Ian M Schwartz, Fang Qian, et al.
Blood|October 19, 2007
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablastsClaudia Bossen, Teresa G Cachero, Aubry Tardivel, et al.
Cancer Research Communications|June 9, 2025
Defining Non-small Cell Lung Cancer Tumor Microenvironment Changes at Primary and Acquired Immune Checkpoint Inhibitor Resistance Using Clinical and Real-World DataLang Ho Lee, Xin Xu, Thanos Mourikis, et al.
JTO Clinical and Research Reports|August 14, 2025
CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB-IIIA NSCLCJay M Lee, Jean-Louis Pujol, Jun Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2023
Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical TrialEdward B Garon, Shun Lu, Yasushi Goto, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 22, 2026
Targeting CRTC2 reverses STK11 mutant NSCLC tumor resistance to immunotherapyDimitri Robay, Ole Ackermann, Laurent Laborde, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 25, 2011
CCCTC-binding factor (CTCF) and cohesin influence the genomic architecture of the Igh locus and antisense transcription in pro-B cellsStephanie C Degner, Jiyoti Verma-Gaur, Timothy P Wong, et al.
Pageof 3